← Leaderboards
Katherine M Detre
University Of Pittsburgh At Pittsburgh
$11,537,889
Attributed
$11,537,889
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$44,825,932 · 7
By mechanism
U01$44,825,932 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dana Young Fuhrman$1,151,344
- John Gorcsan$5,229,019
- David Alan Vorp$12,987,916
- Richard Schulz$11,087,666
- William R Wagner$18,616,539
Others in their field
Top investigators on “Cooperative Study”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,953,039
- Eric S Lander · Whitehead Institute For Biomedical Res$342,301,804
- David R. Weir · University Of Michigan At Ann Arbor$323,894,310
- Norman Wolmark · Nsabp Foundation, Inc.$217,977,635
- Gregory H Reaman · National Childhood Cancer Foundation$202,419,402
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$201,297,180
Research focus
Cooperative StudyLongitudinal Human StudyHuman Therapy EvaluationCoronary DisorderClinical ResearchHuman DataCoronary BypassHeart RevascularizationInsulin Sensitivity /ResistanceNoninsulin Dependent Diabetes MellitusMyocardial Ischemia /HypoxiaEpidemiologyDisease /Disorder Proneness /RiskRelapse /RecurrenceData ManagementCardiovascular Disorder EpidemiologyBlood GlucoseHeart Disorder ChemotherapyInsulinFibrinolysisDiabetes Mellitus TherapyAngina PectorisHuman SubjectNonsurgical Revascularization
Grant awards (30)
Dynamic Evaluation of Coronary Intervention$741,144
U01 · FY2005 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$39,198
U01 · FY2005 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$7,771,898
U01 · FY2004 · HL
Dynamic Evaluation of Coronary Intervention$742,499
U01 · FY2004 · HL
Bari Ii:Foreign Recruitment$44,370
U01 · FY2004 · HL
Bari Ii: Domestic Recruitment$33,124
U01 · FY2004 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$7,746,523
U01 · FY2003 · HL
Dynamic Evaluation of Coronary Intervention$744,582
U01 · FY2003 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$20,279
U01 · FY2003 · HL
BARI II: Domestic Recruitment$0
U01 · FY2003 · HL
BARI II:Foreign Recruitment$0
U01 · FY2003 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$7,909,028
U01 · FY2002 · HL
BARI DATA COORDINATING CENTER$1,455,489
U01 · FY2002 · HL
LONG TERM FOLLOW UP OF THE NIDDK LTD$603,442
U01 · FY2002 · DK
Core--Coordinating and data$292,369
U01 · FY2002 · HL
Core--Coordinating and data$292,369
U01 · FY2002 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$5,425,054
U01 · FY2001 · HL
BARI DATA COORDINATING CENTER$1,548,634
U01 · FY2001 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$700,000
U01 · FY2001 · HL
DYNAMIC EVALUATION OF PERCUTANEOUS CORONARY INTERVENTION$655,805
U01 · FY2001 · HL
LONG TERM FOLLOW UP OF THE NIDDK LTD$596,669
U01 · FY2001 · DK
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$300,000
U01 · FY2001 · HL
Core--Coordinating and data$292,369
U01 · FY2001 · HL
Core--Coordinating and data$292,369
U01 · FY2001 · HL
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$3,376,063
U01 · FY2000 · HL
BARI DATA COORDINATING CENTER$1,634,262
U01 · FY2000 · HL
DYNAMIC EVALUATION OF PERCUTANEOUS CORONARY INTERVENTION$662,286
U01 · FY2000 · HL
LONG TERM FOLLOW UP OF THE NIDDK LTD$589,825
U01 · FY2000 · DK
Core--Coordinating and data$292,369
U01 · FY2000 · HL
LONG TERM FOLLOW UP OF THE NIDDK LTD$23,913
U01 · FY2000 · DK